NTLA
Intellia Therapeutics
$10.67
−$0.06 (−0.56%)Jul 27, 2026
Key metrics
The numbers that frame NTLA today
- Market cap
- $1.49B
- P/E (TTM)
- -3.8
- EV / FCF
- -4.0
- Gross margin
- 100%
- EV / Sales
- 21.7
- ROIC
- -56.6%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $7.95
- 52wk High
- $28.24
Growth
Revenue and earnings trend for NTLA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NTLA
Is Intellia Therapeutics a good buy?
No. Intellia Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Intellia Therapeutics is selling at a very high price.
What is the market capitalization of NTLA?
Intellia Therapeutics's market capitalization is $1.49B.
What is the P/E ratio for NTLA stock?
Intellia Therapeutics's current P/E ratio is -3.8.
What is the 52-week high for NTLA stock?
The 52-week high for Intellia Therapeutics is $28.24. The current close of $10.67 is 62.2% below that high.
What is the 52-week low for NTLA stock?
The 52-week low for Intellia Therapeutics is $7.95. The current close of $10.67 is 34.2% above that low.
Does NTLA stock pay dividends?
Intellia Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NTLA?
Intellia Therapeutics's Debt / Equity ratio is 0.13.